Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative Colitis
Author:
Affiliation:
1. Department of Gastroenterology, Mater Hospital , Brisbane , Australia
2. Department of Medicine, University of Queensland , Brisbane , Australia
3. Mater Research Institute , Brisbane , Australia
4. Mater Private Hospital , Brisbane , Australia
Abstract
Publisher
Oxford University Press (OUP)
Subject
Gastroenterology,General Medicine
Link
https://academic.oup.com/ecco-jcc/advance-article-pdf/doi/10.1093/ecco-jcc/jjad115/50949272/jjad115.pdf
Reference10 articles.
1. The pattern and outcome of acute severe colitis;Dinesen;J Crohns Colitis,2010
2. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: A parallel, open-label randomised controlled trial;Laharie;Lancet [London, England],2012
3. Response to corticosteroids in severe ulcerative colitis: A systematic review of the literature and a meta-regression;Turner;Clin Gastroenterol Hepatol,2007
4. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: Results from three phase 3, multicentre, double-blind, randomised trials;Danese;Lancet [London, England],2022
5. Sequential use of high-dose tofacitinib after infliximab salvage therapy in acute severe ulcerative colitis;Gilmore;J Crohns Colitis,2022
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Acute Severe Ulcerative Colitis: Review of Management and Emerging Treatments;Canadian IBD Today;2024-09-11
2. Upadacitinib as salvage therapy in adolescents with acute severe ulcerative colitis refractory to conventional treatments;JPGN Reports;2024-09-05
3. Upadacitinib for Acute Severe Ulcerative Colitis: A Systematic Review;Inflammatory Bowel Diseases;2024-08-26
4. Navigating treatment resistance: Janus kinase inhibitors for ulcerative colitis;World Journal of Clinical Cases;2024-08-26
5. Predicting Outcome after Acute Severe Ulcerative Colitis: A Contemporary Review and Areas for Future Research;Journal of Clinical Medicine;2024-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3